Production (Stage)
Cardiff Oncology, Inc.
CRDF
$3.86
$0.051.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.90% | 22.62% | -29.12% | -32.55% | -30.71% |
| Total Receivables | 3.05% | 32.09% | 212.12% | 180.12% | -41.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.37% | 25.51% | -55.33% | -53.02% | -41.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.18% | 22.79% | -29.29% | -32.87% | -31.22% |
|
|
|||||
| Total Current Assets | 18.18% | 22.79% | -29.29% | -32.87% | -31.22% |
| Net Property, Plant & Equipment | -33.68% | -29.84% | -27.31% | -24.00% | -19.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -79.84% | -94.61% | -8.65% | -8.56% | -6.32% |
| Total Assets | 14.55% | 19.05% | -28.89% | -32.22% | -30.51% |
|
|
|||||
| Total Accounts Payable | -30.09% | 145.22% | 113.08% | 73.80% | 78.14% |
| Total Accrued Expenses | 35.06% | 1.46% | 16.65% | 22.01% | 30.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.87% | 2.75% | 2.76% | 2.78% | 2.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.23% | 28.62% | 38.89% | 37.26% | 45.35% |
|
|
|||||
| Total Current Liabilities | 12.23% | 28.62% | 38.89% | 37.26% | 45.35% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -50.81% | -44.24% | -39.08% | -34.91% | -31.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.99% | 19.69% | 27.10% | 25.63% | 30.84% |
|
|
|||||
| Common Stock & APIC | 14.32% | 14.11% | 3.25% | 1.36% | 0.96% |
| Retained Earnings | -14.01% | -13.15% | -12.78% | -12.50% | -12.75% |
| Treasury Stock & Other | 120.45% | 150.75% | 120.15% | 77.49% | -73.68% |
| Total Common Equity | 16.39% | 18.94% | -36.54% | -39.49% | -36.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.39% | 18.94% | -36.54% | -39.49% | -36.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.39% | 18.94% | -36.54% | -39.49% | -36.90% |
|
|
|||||